Dr Andrew Srisuwananukorn on the Potential for AI in Differe

Andrew Srisuwananukorn, MD, of the Ohio State University Comprehensive Cancer Center, explained the potential of artificial intelligence (AI)-based support tools for differentiating primary myelofibrosis (prePMF) and essential thrombocythemia (ET) in the community setting.

Related Keywords

United States , American , Andrew Srisuwananukorn , Ohio State University Comprehensive Cancer Center , American Society Of Hematology Annual Meeting , Hematology Annual Meeting , Myelofibrosis , Primary Myelofibrosis , Essential Thrombocythemia , D ,